https://www.selleckchem.com/pr....oducts/idf-11774.htm
27% of patients with FC II; p 16 ng/mL and 13-16 ng/mL are risk factors for mid- and long-term cardiac complications, respectively.Objective Carry out a comparative assessment of respiratory performance, based on multifunctional monitoring (MFM) and the recommended practice for complete polysomnography (PSG), and evaluate the effect of the blood pressure (BP) measurements in MFM on the quality of sleep.Materials and Methods At the first stage, 22 healthy volunteers (control group) underwent concomitant PSG and MFM, and 14 patients wit
Like
Comment
Share
